Iran’s Official Medicine Market Hollowed Out by Policy Instability and Currency Crisis
Industry figures and officials warn that policy instability, currency disruptions, and shortages are driving patients toward illegal sellers and counterfeit drugs in Iran.
Iran’s official medicine market is being hollowed out as a combination of policy instability, currency disruptions, and severe shortages forces patients to seek alternatives outside the regulated system.
According to warnings from industry figures and officials, the deteriorating situation is pushing more patients toward illegal sellers, counterfeit drugs, and informal supply networks. The currency crisis has made imported medicines prohibitively expensive, while domestic production struggles with raw material shortages.
The breakdown in the official supply chain threatens public health and undermines regulatory control over pharmaceutical quality and pricing.
Source: First Squawk